Nieuws en video's - HOLOGIC INC. - Pagina 3

Hologic, Inc. (Nasdaq: HOLX) announced today that Stacey D. Stewart has been elected to the Company’s Board of Directors, effective January 2, 2023. Ms. Stewart was also appointed to the Audit and Finance Committee effective January 2, 2023. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221209005067/en/ Stacey D. Stewart (Photo: Business Wire) Ms. Stewart has served as President and CEO of March of Dimes Inc., a leading non-profit...

Hologic, Inc. (Nasdaq: HOLX) and its subsidiary, Biotheranostics, Inc., today announced new study data showing that the Breast Cancer Index test identified which premenopausal patients with early-stage, hormone-receptor positive (HR+) breast cancer benefited from the addition of ovarian function suppression (OFS) to primary adjuvant endocrine therapy. The Breast Cancer Index test is the first biomarker to be evaluated in a cohort from the landmark Suppression of Ovarian Function Trial (SOFT)....

Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health, swept the 2022 IMV ServiceTrak™ Awards for Mammography, taking home awards for Best Service, Best Customer Satisfaction and Best System Performance. This is the 10 th consecutive year that Hologic has ranked first in the industry for Mammography System Performance and Customer Satisfaction and the eighth year for Mammography Service. “We are thrilled to win the IMV Award...

Hologic, Inc. (Nasdaq: HOLX) will exhibit its extensive portfolio of breast and skeletal health products at the 108 th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 27 to Dec. 1. Among the full suite of breast biopsy and surgery solutions will be Hologic’s Affirm ® Contrast Biopsy software, which will be on display for the first time since becoming commercially available in the United States. “As the global leader in breast imaging, we...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present virtually at the 5 th Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, at 2:40 p.m. Eastern Time. The fire-side chat presentation will be webcast live and may be accessed through a link on the investor’s section of Hologic’s website at http://investors.hologic.com . The webcast will be available for 30 days following the event. About Hologic, Inc. Hologic, Inc. is an innovative medical...

Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that its 3Dimensions™ mammography system was awarded EUREF Type Test certification by the European Reference Organisation for Quality Assured Breast Screening and Diagnostic Services ( www.EUREF.org ). 1 It is the first digital breast tomosynthesis (DBT) system to receive such a distinction, and one of only nine mammography systems overall to earn certification. The mission of the nonprofit EUREF organisation is...

Hologic, Inc. (Nasdaq: HOLX) announced today that it has been awarded a $19 million contract from the Biomedical Advanced Research and Development Authority (BARDA) to support research and development efforts. This funding will help to bring Hologic’s Panther Fusion ® SARS-CoV-2/Flu A/B/RSV assay and Aptima ® SARS-CoV-2 assay in line with the U.S. Food and Drug Administration’s (FDA) in vitro diagnostic (IVD) standards. Hologic’s Aptima ® SARS-CoV-2 assay received Emergency Use...

Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal fourth quarter ended September 24, 2022 . “In our fourth quarter of fiscal 2022, Hologic delivered excellent results that significantly exceeded expectations, topping off another tremendous year,” said Steve MacMillan, the Company’s chairman, president and chief executive officer. “Fiscal 2022 was outstanding for Hologic. We dramatically strengthened our base businesses, responded with agility...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2022 on Monday, October 31, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing (800) 263-0877 (in the United States and Canada) or +1 (323) 794-2094 (for international callers) and referencing access code 9021328. Participants...

Hologic, Inc. Chairman, President and CEO Steve MacMillan will ring the Nasdaq opening bell today to mark the beginning of Breast Cancer Awareness Month. This is the 16 th time that Hologic (Nasdaq: HOLX), an innovative medical technology company and the pioneer of 3D mammography, will ring the bell to raise awareness about breast cancer. MacMillan will be joined by Hologic employees and members of the Women’s Tennis Association (WTA), including tennis legend and breast cancer survivor Martina...

More than 1.5 billion women worldwide lack screenings for cancer, heart disease, diabetes or sexually transmitted diseases/infections – even though these conditions together affect billions of women. The finding comes from one of the world’s largest studies of women’s well-being: the second annual Hologic Global Women’s Health Index. The report, released today, identifies many barriers to preventive care for women. These hurdles include struggles to find enough food and shelter, lack of...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: Wells Fargo’s Healthcare Conference on Wednesday, September 7 at 9:45 a.m. Eastern Time (ET). Morgan Stanley’s 20 th Annual Global Healthcare Conference on Tuesday, September 13 at 12:20 p.m. ET. Each presentation will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://investors.hologic.com . The webcasts will be...

Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, and Grammy award-winning and Oscar-nominated artist, producer, and entrepreneur Mary J. Blige today announced the launch of the “Good Morning Gorgeous” sweepstakes. The sweepstakes is an element of Hologic’s role as presenting sponsor of Blige’s “Good Morning Gorgeous” tour, which is presented in partnership with The Black Promoters Collective (BPC) and will take place September 17 through October 29, 2022. The...

Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a 2018 district court ruling that barred Minerva from challenging the validity of the patent rights it assigned to Hologic. “We are pleased that the U.S. Court of Appeals has once again ruled in our favor. This important decision confirms that good faith and fair dealing apply to transactions involving patents and provides greater certainty for companies like Hologic who acquire...

Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal third quarter ended June 25, 2022 . “In our third quarter of fiscal 2022, Hologic delivered exceptionally strong growth in our base Diagnostics and Surgical franchises, powering financial results that meaningfully exceeded our guidance for both revenue and profitability,” said Steve MacMillan, the Company’s chairman, president and chief executive officer. “With strength in our base business, a...

Hologic, Inc. (Nasdaq: HOLX) will showcase their comprehensive portfolio of breast and skeletal health solutions at the annual European Congress of Radiology (ECR) in Vienna, Austria from July 13-17. The pioneer behind 3D Mammography™ technology, Hologic will provide attendees with an interactive experience that underscores a commitment to innovation through advancements in breast screening, surgery, biopsy and ultrasound solutions. As visitors explore the clinically proven, integrated...

Hologic, Inc. (Nasdaq: HOLX) announced today that it is now offering its Panther Fusion ® SARS-CoV-2/Flu A/B/RSV assay and its Novodiag ® RESP-4 molecular diagnostic test for sale in the European Union in time for the northern hemisphere’s respiratory viral season. Both assays detect and differentiate four of the most prevalent respiratory viruses that can present with similar clinical symptoms: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A (Flu A), influenza B...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2022 on Wednesday, July 27, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing (800) 289-0720 (in the United States and Canada) or +1 (323) 701-0160 (for international callers) and referencing access code 6025981. Participants...

A new survey commissioned by Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, revealed a lack of awareness among U.S. women about uterine health, including uterine fibroid symptoms and treatment options. Today, in conjunction with the start of Fibroid Awareness Month, Hologic is proud to announce the launch of Hey, U! , an educational campaign focused on uterine health. Uterine fibroids are very common, affecting up to 80% of women by the age of 50. 1 Even so, Hologic's survey...

Hologic, Inc. (Nasdaq: HOLX) announced it has received CE marking for two new molecular assays, Panther Fusion EBV Quant Assay and Panther Fusion BKV Quant Assay, expanding its transplant pathogen monitoring menu on the Panther Fusion system. The assays quantify the viral load of the respective viruses and are intended to aid the diagnosis and management of solid organ transplant patients and hematopoietic stem cell transplant patients. The assays are in vitro nucleic acid amplification tests...